Aspiriant LLC’s Abaxis Inc ABAX Stock Holding History

Aspiriant LLC’s Portfolio ABAX Stock Details ABAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-8,000	Closed	-$388K	–	236
2017 Q1	$388K	Buy	+8,000	New	+$397K	0.03%	160

Other funds holding ABAX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aspiriant LLC's ABAX Position: Q2 2017 in Review

Aspiriant LLC sold out of Abaxis Inc (ABAX) in Q2 2017, closing a stake of 8,000 shares — an estimated $388K sold.

Aspiriant LLC first reported a position in ABAX in Q1 2017 and held it in 1 quarter. The position peaked at $388K in Q1 2017. 129 funds tracked by Wall St. Rank hold ABAX as of Q2 2017.

Aspiriant LLC reported no remaining Abaxis Inc position as of Q2 2017 after selling out during the quarter.
Aspiriant LLC sold 8,000 Abaxis Inc shares in Q2 2017, an estimated $388K.
Aspiriant LLC first reported a position in Abaxis Inc in Q1 2017 and held it in 1 quarter.
Aspiriant LLC's Abaxis Inc position peaked at $388K in Q1 2017.
129 funds tracked by Wall St. Rank held Abaxis Inc as of Q2 2017.

Based on Aspiriant LLC's 13F filing for Q2 2017, filed 3 Aug 2017.